Trials / Completed
CompletedNCT00718120
Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years
Immunogenicity and Safety Study of a Single Injection of GSK Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral® (2008 - 2009 Season) in Adults Aged 18 to 60 Years and Over 60 Years.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the immunogenicity and safety of GSK Biologicals' Trivalent split virion influenza vaccine Fluviral for the 2008-2009 season in adults over the age of 18.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Fluviral® | One intramuscular injection into the deltoid region of the non-dominant arm |
Timeline
- Start date
- 2008-07-18
- Primary completion
- 2008-08-09
- Completion
- 2008-08-09
- First posted
- 2008-07-18
- Last updated
- 2019-06-26
- Results posted
- 2009-08-25
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00718120. Inclusion in this directory is not an endorsement.